Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial
LLLuisa L. VillaRLRonaldo Lúcio Rangel CostaCACarlos Alberto PettaRPRosíres Pereira de AndradeKAKevin A. Ault
Ludwig Cancer Research · Instituto Brasileiro de Controle do Câncer · +19 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
1,579
total citations
- FWCI
- 132.10
- Percentile
- 100%
- References
- 31
Citations per year
Authors
29Topics & keywords
Topics
Keywords
- Placebo
- Medicine
- Double blind
- Virus-like particle
- Human papillomavirus
- Internal medicine
- Virology
- Recombinant DNA
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.